SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (723)2/25/2000 11:41:00 PM
From: Larry Liebman  Read Replies (2) | Respond to of 52153
 
Interesting take on genomics companies on marketwatch.com. Notes that cap of the genomic leaders approaches $60 billion, which may appear expensive, until you factor in AOL itself is capitalized on the order of $135 billion. BTW, AOL has 2 billion shares out. Take a look at how many shares that INCY, CRA, AFFX, HGSI, MLNM, MYGN, CRGN, GLGC... have outstanding....maybe 1/10 of AOL.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News